IP Library Granted Patent US 9,296,820
Granted Patent B2
US 9,296,820 · App. 10/981,738 · Granted Mar 29, 2016

Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function

Inventors: Pablo Umaña (Zurich, CH); Peter Brünker (Hittnau, CH); Claudia Ferrara Koller (Zug, CH); Tobias Suter (Windisch, CH); Ursula Püntener (Windisch, CH); Ekkehard Mössner (Kreuzlingen, CH)
Assignee: Roche GlycArt AG
C07K16/2887A61K2039/505C07K2317/24C07K2317/41C07K2317/52C07K2317/53C07K2317/56C07K2317/567C07K2317/72C07K2317/732C07K2317/734C07K2317/92C12N15/11C12N15/63Y10S530/808Y10S530/866Y10S530/867
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,296,820
App. No.
10/981,738
Granted
Mar 29, 2016
Kind
B2
Abstract

The present invention relates to nucleic acids encoding anti-CD20 antigen binding molecules (ABMs). In particular embodiments, the present invention relates to nucleic acid encoding recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In some embodiments, the invention relates to an isolated polynucleotide comprising a) a sequence encoding a polypeptide having a sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76. In addition, the present invention relates to vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.

Claims (28)

1. An isolated polynucleotide comprising

a) a sequence encoding a polypeptide having a sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and

b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76.

2. A composition comprising an isolated first polynucleotide that encodes a polypeptide that comprises an immunoglobulin heavy chain variable region comprising the amino acid sequence of SEQ ID NO:40, and an isolated second polynucleotide that encodes a polypeptide that comprises an immunoglobulin light chain variable region comprising the amino acid sequence of SEQ ID NO:76.

3. An in vitro cultured host cell comprising a first polynucleotide that encodes a polypeptide that comprises an immunoglobulin heavy chain variable region comprising the amino acid sequence of SEQ ID NO:40, and a second polynucleotide that encodes a polypeptide that comprises an immunoglobulin light chain variable region comprising the amino acid sequence of SEQ ID NO:76.

4. The isolated polynucleotide of claim 1 , wherein said polypeptide of a) has a sequence of SEQ ID NO:40.

5. The isolated polynucleotide of claim 1 , wherein said sequence encoding the polypeptide of a) further encodes a human Fc region.

6. The isolated polynucleotide of claim 5 , wherein said human Fc region is a human IgG Fc region.

7. The composition of claim 2 , wherein said first polynucleotide further encodes a human Fc region.

8. The composition of claim 7 , wherein said human Fc region is a human IgG Fc region.

9. The in vitro cultured host cell of claim 3 , wherein said first polynucleotide further encodes a human Fc region.

10. The in vitro cultured host cell of claim 9 , wherein said human Fc region is a human IgG Fc region.

11. The in vitro cultured host cell of claim 3 , wherein said host cell is a mammalian cell or a yeast cell.

12. The in vitro cultured host cell of claim 3 , wherein said host cell is a Chinese hamster ovary (CHO) cell.

13. An in vitro cultured host cell comprising

a) a polynucleotide encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:40; SEQ ID NO:32; SEQ ID NO:56; and SEQ ID NO:60; and

b) a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:76.

14. The in vitro cultured host cell of claim 13 , wherein said polynucleotide of a) encodes a polypeptide having the amino acid sequence of SEQ ID NO:40.

15. The in vitro cultured host cell of claim 13 , wherein said polynucleotide of a) further encodes a human Fc region.

16. The in vitro cultured host cell of claim 15 , wherein said human Fc region is a human IgG Fc region.

17. The in vitro cultured host cell of claim 13 , wherein said host cell is a mammalian cell or a yeast cell.

18. The in vitro cultured host cell of claim 13 , wherein said host cell is a CHO cell.

19. The in vitro cultured host cell of claim 13 , wherein the host cell produces an antibody encoded by said polynucleotides of a) and b).

20. A CHO cell comprising a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:40, and a polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:76.

21. The CHO cell of claim 20 , wherein the cell produces an antibody encoded by said polynucleotides.

22. An expression vector comprising a polynucleotide comprising

a) a sequence encoding a polypeptide having the sequence of SEQ ID NO:40; and

b) a sequence encoding a polypeptide having the sequence of SEQ ID NO:76.

Assignments (2)
CHANGE OF NAME Recorded Sep 9, 2011
From: GLYCART BIOTECHNOLOGY AG
To: ROCHE GLYCART AG
Reel/Frame 026883/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2005
From: UMANA, PABLO; BRUNKER, PETER; FERRARA, CLAUDIA; SUTER, TOBIAS; PUNTENER, URSULA; MOSSNER, EKKEHARD
To: GLYCART BIOTECHNOLOGY AG
Reel/Frame 015689/0163 →
Continuity (2)
Provisional Application 60517096 · Nov 5, 2003
Related Publication 20050123546A1 · Jun 9, 2005